Guangdong True Health Medical Technology Development Co., Ltd. (HKG:2697)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
580.00
+101.20 (21.14%)
Jul 14, 2026, 4:08 PM HKT

HKG:2697 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
12.181.792.3
Revenue Growth (YoY)
579.96%-22.16%-
Cost of Revenue
2.880.480.42
Gross Profit
9.291.311.89
Selling, General & Admin
86.2974.9557.83
Research & Development
56.8750.8540.75
Other Operating Expenses
0.120.03-
Operating Expenses
143.29125.8398.58
Operating Income
-133.99-124.52-96.69
Interest Expense
-0.4-0.59-0.44
Interest & Investment Income
2.871.320.76
Earnings From Equity Investments
-0.16--
Other Non Operating Income (Expenses)
41.5731.610.48
EBT Excluding Unusual Items
-90.12-92.18-95.89
Asset Writedown
---0
Other Unusual Items
00.030.35
Pretax Income
-90.11-92.15-95.54
Income Tax Expense
00-
Earnings From Continuing Operations
-90.11-92.16-95.54
Minority Interest in Earnings
--0.61
Net Income
-90.11-92.16-94.93
Net Income to Common
-90.11-92.16-94.93
Shares Outstanding (Basic)
312422
Shares Outstanding (Diluted)
312422
Shares Change (YoY)
26.72%11.61%-
EPS (Basic)
-2.95-3.82-4.40
EPS (Diluted)
-2.95-3.82-4.40
Free Cash Flow
-94.94-104.91-97.24
Free Cash Flow Per Share
-3.11-4.35-4.50
Gross Margin
76.32%73.14%81.96%
Operating Margin
-1100.27%-6952.26%-4202.22%
Profit Margin
-739.97%-5145.51%-4125.51%
Free Cash Flow Margin
-779.60%-5857.79%-4225.99%
EBITDA
-127.76-118.88-92.96
D&A For EBITDA
6.235.643.73
EBIT
-133.99-124.52-96.69